+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Flow Diversion Aneurysm Treatment Market 2021-2025

  • PDF Icon

    Report

  • 120 Pages
  • August 2021
  • Region: Global
  • TechNavio
  • ID: 5031226
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The publisher has been monitoring the flow diversion aneurysm treatment market and it is poised to grow by $ 1.75 bn during 2021-2025, progressing at a CAGR of 8.26% during the forecast period. The report on the flow diversion aneurysm treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of IAs and associated risk factors, increasing preference for flow diversion aneurysm treatment, and improvements in detection of UIAs.

The flow diversion aneurysm treatment market analysis includes the product segment and geographic landscape.

The flow diversion aneurysm treatment market is segmented as below:


By Product

  • Intrasaccular flow disruption devices
  • FDS

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • ROW

This study identifies the increasing R&D focus as one of the prime reasons driving the flow diversion aneurysm treatment market growth during the next few years. Also, expanding indications and integration of advanced technologies in aneurysm treatment will lead to sizable demand in the market.

The report on flow diversion aneurysm treatment market covers the following areas:

  • Flow diversion aneurysm treatment market sizing
  • Flow diversion aneurysm treatment market forecast
  • Flow diversion aneurysm treatment market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading flow diversion aneurysm treatment market vendors that include Acandis GmbH, Boston Scientific Corp., Cardinal Health Inc., Cook Group Inc., Johnson and Johnson Inc., Medtronic Plc, MicroPort Scientific Corp., phenox GmbH, Stryker Corp., and Terumo Corp. Also, the flow diversion aneurysm treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2020
  • Market outlook: Forecast for 2020 - 2025

Five Forces Analysis

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Product

  • Market segments
  • Comparison by Product
  • FDS - Market size and forecast 2020-2025
  • Intrasaccular flow disruption devices - Market size and forecast 2020-2025
  • Market opportunity by Product

Customer landscape

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2020-2025
  • Europe - Market size and forecast 2020-2025
  • Asia - Market size and forecast 2020-2025
  • ROW - Market size and forecast 2020-2025
  • Key leading countries
  • Market opportunity By Geographical Landscape
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape

  • Overview
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Acandis GmbH
  • Boston Scientific Corp.
  • Cardinal Health Inc.
  • Cook Group Inc.
  • Johnson and Johnson Inc.
  • Medtronic Plc
  • MicroPort Scientific Corp.
  • phenox GmbH
  • Stryker Corp.
  • Terumo Corp.

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

List of Exhibits

  • Key Finding 1
  • Key Finding 2
  • Key Finding 3
  • Key Finding 5
  • Key Finding 6
  • Key Finding 7
  • Key Finding 8
  • Parent market
  • Market characteristics
  • Offerings of vendors included in the market definition
  • Market segments
  • Global - Market size and forecast 2020 - 2025 ($ million)
  • Global market: Year-over-year growth 2020 - 2025 (%)
  • Five forces analysis 2020 & 2025
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition - Five forces 2020
  • Product - Market share 2020-2025 (%)
  • Comparison by Product
  • FDS - Market size and forecast 2020-2025 ($ million)
  • FDS - Year-over-year growth 2020-2025 (%)
  • Intrasaccular flow disruption devices - Market size and forecast 2020-2025 ($ million)
  • Intrasaccular flow disruption devices - Year-over-year growth 2020-2025 (%)
  • Market opportunity by Product
  • Customer landscape
  • Market share By Geographical Landscape 2020-2025 (%)
  • Geographic comparison
  • North America - Market size and forecast 2020-2025 ($ million)
  • North America - Year-over-year growth 2020-2025 (%)
  • Europe - Market size and forecast 2020-2025 ($ million)
  • Europe - Year-over-year growth 2020-2025 (%)
  • Asia - Market size and forecast 2020-2025 ($ million)
  • Asia - Year-over-year growth 2020-2025 (%)
  • ROW - Market size and forecast 2020-2025 ($ million)
  • ROW - Year-over-year growth 2020-2025 (%)
  • Key leading countries
  • Market opportunity By Geographical Landscape ($ million)
  • Impact of drivers and challenges
  • Vendor landscape
  • Landscape disruption
  • Industry risks
  • Vendors covered
  • Market positioning of vendors
  • Acandis GmbH - Overview
  • Acandis GmbH - Product and service
  • Acandis GmbH - Key offerings
  • Acandis GmbH - Key customers
  • Acandis GmbH - Segment focus
  • Boston Scientific Corp. - Overview
  • Boston Scientific Corp. - Business segments
  • Boston Scientific Corp. - Key offerings
  • Boston Scientific Corp. - Key customers
  • Boston Scientific Corp. - Segment focus
  • Cardinal Health Inc. - Overview
  • Cardinal Health Inc. - Business segments
  • Cardinal Health Inc. - Key offerings
  • Cardinal Health Inc. - Key customers
  • Cardinal Health Inc. - Segment focus
  • Cook Group Inc. - Overview
  • Cook Group Inc. - Product and service
  • Cook Group Inc. - Key offerings
  • Cook Group Inc. - Key customers
  • Cook Group Inc. - Segment focus
  • Johnson and Johnson Inc. - Overview
  • Johnson and Johnson Inc. - Business segments
  • Johnson and Johnson Inc. - Key offerings
  • Johnson and Johnson Inc. - Key customers
  • Johnson and Johnson Inc. - Segment focus
  • Medtronic Plc - Overview
  • Medtronic Plc - Business segments
  • Medtronic Plc - Key offerings
  • Medtronic Plc - Key customers
  • Medtronic Plc - Segment focus
  • MicroPort Scientific Corp. - Overview
  • MicroPort Scientific Corp. - Business segments
  • MicroPort Scientific Corp. - Key offerings
  • MicroPort Scientific Corp. - Key customers
  • MicroPort Scientific Corp. - Segment focus
  • phenox GmbH - Overview
  • phenox GmbH - Product and service
  • phenox GmbH - Key offerings
  • phenox GmbH - Key customers
  • phenox GmbH - Segment focus
  • Stryker Corp. - Overview
  • Stryker Corp. - Business segments
  • Stryker Corp. - Key offerings
  • Stryker Corp. - Key customers
  • Stryker Corp. - Segment focus
  • Terumo Corp. - Overview
  • Terumo Corp. - Business segments
  • Terumo Corp. - Key offerings
  • Terumo Corp. - Key customers
  • Terumo Corp. - Segment focus
  • Currency conversion rates for US$
  • Research Methodology
  • Validation techniques employed for market sizing
  • Information sources
  • List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global flow diversion aneurysm treatment market: Acandis GmbH, Boston Scientific Corp., Cardinal Health Inc., Cook Group Inc., Johnson and Johnson Inc., Medtronic Plc, MicroPort Scientific Corp., phenox GmbH, Stryker Corp., and Terumo Corp.

Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is increasing R&D focus.`

According to the report, one of the major drivers for this market is the increasing prevalence of IAs and associated risk factors.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Acandis GmbH
  • Boston Scientific Corp.
  • Cardinal Health Inc.
  • Cook Group Inc.
  • Johnson and Johnson Inc.
  • Medtronic Plc
  • MicroPort Scientific Corp.
  • phenox GmbH
  • Stryker Corp.
  • Terumo Corp.